for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Thiel-backed psychedelics startup Atai valued at over $3 bln in Nasdaq debut

June 18 (Reuters) - Shares of Atai Life Sciences B.V., backed by billionaire investor Peter Thiel, jumped 40% in their U.S. stock market debut on Friday, giving the German psychedelics startup a market capitalization of $3.19 billion.

Reporting by Sohini Podder and Niket Nishant in Bengaluru; Editing by Devika Syamnath

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up